Objective To analyze the clinical effect of Liujunzi Decoction in treatment of patients with advanced gastric cancer differentiated as type of deficiency of spleen qi.
Methods A total of 100 patients with advanced gastric cancer differentiated as type of deficiency of spleen qi were divided into control group and observation group, with 50 cases in each group. All the patients were treated with apatinib tablets. On this basis, the control group was treated with metoclopramide tablets, while the observation group was treated with modified Liujunzi Decoction. The clinical effect was compared between the two groups.
Results The total effective rate and the incidence rate of adverse reactions in the observation group were significantly better than those in the control group (P < 0.05).
Conclusion Modified Liujunzi Decoction is effective in the treatment of patients with advanced gastric cancer differentiated as type of deficiency of spleen qi, and has iower incidence rate of adverse reactions.
DownLoad: